| WKN: | A3DMB5 |
| ISIN: | GB00BN7SWP63 |
| Land: | Großbritannien |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Pharma |
Weshalb die GlaxoSmithKline-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 06. Dezember 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 1997 | 12,96 | 22,00 | 69,75% |
| 2 | 1998 | 22,00 | 29,64 | 34,73% |
| 3 | 2021 | 15,53 | 19,84 | 27,75% |
| 4 | 2019 | 16,80 | 21,35 | 27,08% |
| 5 | 2005 | 17,29 | 21,82 | 26,20% |
| 6 | 2025 | 16,40 | 20,61 | 25,67% |
| 7 | 2011 | 15,15 | 17,71 | 16,90% |
| 8 | 2013 | 16,82 | 19,45 | 15,64% |
| 9 | 2009 | 12,98 | 14,80 | 14,02% |
| 10 | 2018 | 15,15 | 16,80 | 10,89% |
| 11 | 2000 | 27,88 | 30,71 | 10,15% |
| 12 | 2015 | 17,91 | 18,94 | 5,75% |
| 13 | 2003 | 17,42 | 18,38 | 5,51% |
| 14 | 2023 | 16,24 | 16,68 | 2,71% |
| 15 | 2010 | 14,80 | 15,15 | 2,36% |
| 16 | 2024 | 16,68 | 16,40 | -1,68% |
| 17 | 2016 | 18,94 | 18,60 | -1,80% |
| 18 | 2012 | 17,71 | 16,82 | -5,03% |
| 19 | 2004 | 18,38 | 17,29 | -5,93% |
| 20 | 1999 | 29,64 | 27,88 | -5,94% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2002 | 28,79 | 17,42 | -39,49% |
| 2 | 2020 | 21,35 | 15,53 | -27,26% |
| 3 | 2008 | 17,73 | 12,98 | -26,79% |
| 4 | 2017 | 18,60 | 15,15 | -18,55% |
| 5 | 2022 | 19,84 | 16,24 | -18,15% |
| 6 | 2007 | 20,10 | 17,73 | -11,79% |
| 7 | 2014 | 19,45 | 17,91 | -7,92% |
| 8 | 2006 | 21,82 | 20,10 | -7,88% |
| 9 | 2001 | 30,71 | 28,79 | -6,25% |
| 10 | 1999 | 29,64 | 27,88 | -5,94% |
| 11 | 2004 | 18,38 | 17,29 | -5,93% |
| 12 | 2012 | 17,71 | 16,82 | -5,03% |
| 13 | 2016 | 18,94 | 18,60 | -1,80% |
| 14 | 2024 | 16,68 | 16,40 | -1,68% |
| 15 | 2010 | 14,80 | 15,15 | 2,36% |
| 16 | 2023 | 16,24 | 16,68 | 2,71% |
| 17 | 2003 | 17,42 | 18,38 | 5,51% |
| 18 | 2015 | 17,91 | 18,94 | 5,75% |
| 19 | 2000 | 27,88 | 30,71 | 10,15% |
| 20 | 2018 | 15,15 | 16,80 | 10,89% |